Latest Financial Results
Fiscal Year Ended Dec 31, 2018
Stay informed and receive company updates straight to your inboxSign up today
HJLI specializes in developing and manufacturing bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has three product candidates: the porcine tissue based VenoValve®, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; the CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery, and a porcine tissue based heart valve, which based upon its relatively small size and increased output, is an ideal candidate for pediatric aortic/mitral valve replacement.
Investor Contact Information
Hancock Jaffe Laboratories, Inc.
Irvine, CA 92618
MZ North America
V Stock Transfer LLC